Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease
Abstract Chronic kidney disease (CKD) worsens ischemic stroke severity in both patients and animals. In mice, these poorer functional outcomes are associated with decreased brain activity of AMP-activated protein kinase (AMPK), a molecule that recently emerged as a potential therapeutic target for i...
Guardado en:
Autores principales: | Maria Grissi, Cédric Boudot, Maryam Assem, Alexandre Candellier, Mathilde Lando, Sabrina Poirot-Leclercq, Agnès Boullier, Youssef Bennis, Gaëlle Lenglet, Carine Avondo, Jean-Daniel Lalau, Gabriel Choukroun, Ziad A. Massy, Saïd Kamel, Jean-Marc Chillon, Lucie Hénaut |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f8a2ca6c26c45778bd5905ec65b06e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Determination and modulation of total and surface calcium-sensing receptor expression in monocytes in vivo and in vitro.
por: Julien Paccou, et al.
Publicado: (2013) -
Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.
por: Isabelle Six, et al.
Publicado: (2014) -
Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems
por: Sameer S. Udhane, et al.
Publicado: (2017) -
Entretien
por: Dominique Boullier
Publicado: (2021) -
Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)